Stem Cell Therapy Market Brief Overview by PBI

Posted by venkatakiran on September 27th, 2019

Stem Cell Therapy Market Size and Growth Rate:

“The Global Stem Cell Therapy Market was valued at US$ 135.2 Mn in 2018 and is expected to grow at a significant CAGR over six years forecast period 2019-2025 owing to increasing focus on the development of stem cell banking and processing infrastructure”

Stem Cell Therapy Market Growth Drivers and Restraints:

The global stem cell therapy market was valued at US$ 135.2 Mn in 2018 and growing at a CAGR of 10.7% over the forecast period owing to increasing advancements in technology in curing life threatening diseases and high therapeutic potential of stem cells in genetic diseases treatment are expected to support the growth of the market. Moreover, increasing prevalence of Lysosomal storage diseases such as alpha mannosidosis, Pompe disease, Gaucher disease, etc. where stem cell therapy is necessary in the treatment and the patient population of this rare genetic diseases is increasing year over year and rising government funding as well as private organizations fuels the growth of the market. However, collection of adult stem cell is difficult and high cost of treatment is one parameter that restrains the growth of the market.

Browse More Details of the report @https://www.precisionbusinessinsights.com/market-reports/global-stem-cell-therapy-market/

Allogeneic Stem Cell Therapy segment accounted for higher revenue share

Based on treatment, global stem cell therapy market segmented into allogeneic and autologous. Allogeneic stem cell therapy segment market accounted US$ XX Mn in 2018 and projected to dominate over the forecast period due to increasing adoption and commercialization of this allogeneic stem cell therapy in rare diseases and easy production scale up process coupled with increasing number of clinical trials related to allogeneic stem cell therapy.

North America is expected to grow at Highest CAGR in Global Stem Cell Therapy Market

PBI’s global stem cell therapy market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. According to regional analysis, North America is expected to account for larger revenue share in 2018 and the same trend is projected to follow over 2019-2025 owing to rising prevalence and incidence of chronic diseases mainly rare diseases such as genetic disorders, increasing awareness, and increasing investment in R&D activities. In Asia Pacific region, due to the favorable government policies, developing healthcare infrastructure, industry collaborations in research and developments expected to boost stem cell therapy market..

Strategic Collaborations and Launch of New Products  

Global auto-injectors market further reveals that strategic collaborations and launch of new products in to the market to enhance market revenue share and gaining significant geographic presence across the region. For instance, in April 2017, Plasticell, a developer of stem cell technologies and cell-based therapies, has announced that it has signed agreements with the Agency for Science, Technology and Research (A*STAR), Singapore,  and the Nanyang Technological University (NTU), Singapore, to progress its therapeutic stem cell pipeline. In February 2016, Mesoblast Limited’s licensee in Japan, JCR Pharmaceuticals Co. Ltd., launched “TEMCELL HS Inj”, the first allogeneic cell therapy to be fully approved in Japan, for the treatment of acute graft versus host disease in children and adults

Key player’s profiles in the report are Cytori Therapeutics Inc. (U.S.), Fibrocell Science (U.S.), Cellartis AB (Cellectis) (France), BioTime, Inc. (U.S.), GE Healthcare (U.S.), Thermo Fisher Scientific (U.S.), STEMCELL Technologies Inc. (Canada), Fujifilm Holdings Corporation (Japan), Vericel Corporation (Aastrom Bioscience) (U.S.), Brainstorm cell therapeutics (U.S.), and Osiris Therapeutics, Inc. (U.S.)

Avail Sample of the report for more information @ https://www.precisionbusinessinsights.com/request-sample?product_id=15608

Detailed Segmentation of Stem Cell Therapy Market:

By Treatment 

o  Allogeneic

o  Autologous

By Cell Type  

o  Adult Stem Cells

o  Induced Pluripotent Stem Cells

o  Human Embryonic Stem Cells

o  Others

By Technology

o  Cell Production

o  Cell Acquisition

o  Cryopreservation  

By End User

o  Hospitals

o  Ambulatory Surgical Centers

o  Research Centers

Geography

o     North America

o     Europe

o     Asia-Pacific

o     Latin America

o     Middle East and Africa (MEA)

About Us:

Precision Business Insights is one of the leading market research and management consulting firm, run by a group of seasoned and highly dynamic market research professionals with a strong zeal to offer high-quality insights.

Contact Us:

Shreya Paul

Senior Business Development Executive

Email @ shreya@precisionbusinessinsights.com

Call @ +1-866-598-1553

Precision Business Insights